Study | Description | Exenatide 10 µg BID | Other GLP1 agonist |
---|---|---|---|
versus Liraglutide | |||
L ‐ LEAD 6 Buse 2009 | Diabetes Treatment Satisfaction Questionnaire (6 of 8 items) | 13.3 SD6.94 | 15.18 SD 7.36, P = 0.0004 versus exenatide 10 µg BID |
versus Exenatide 2 mg once weekly | |||
E ‐ Drucker 2008 | Diabetes Treatment Satisfaction Questionnaire (8 of 8 items) | 29.97 | 31.17, P = NS versus exenatide 10 µg BID |